CHRISTINE PECK: Open Payments
NPI 1609101047 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 27 payments from 14 companies in 2025. Trend: 2023 $846 · 2024 $878 · 2025 $767
Food & beverage: $667Education: $100
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 4 | $180 |
| Astellas Pharma US Inc | 4 | $121 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Verona Pharma, Inc. | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $57 |
| Grifols USA, LLC | 2 | $48 |
| HARMONY BIOSCIENCES LLC | 1 | $39 |
| 3B Medical, Inc. | 2 | $39 |
| Philips North America LLC | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: XYWAV, Cresemba, TEZSPIRE, Ohtuvayre, OFEV, Prolastin-C Liquid, WAKIX, LUNA.
Industry payments across NY — which companies pay providers there.
